Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Apr 7.

Published in final edited form as: Neuroscience. 2008 Oct 2;158(2):474–483. doi: 10.1016/j.neuroscience.2008.09.039

The effect of siRNA (“MORD2”) on striatal MOP-r mRNA levels and density is shown in Fig 6. A. Striatal MOP-r mRNA levels in mice infused with siRNA were significantly lower than those of the controls 1 day after infusions (see also a photomicrograph from a representative mouse in 6E). B. Infusions of siRNA into the mouse striatum did not change the MOP-r mRNA levels 7 day after infusions (see also a photomicrograph from a representative mouse in 6F). C. There was not significant difference between the two groups in striatal MOP-r density at day 1 after infusions (see also a photomicrograph from a representative mouse in 6G). D. Striatal MOP-r receptor density levels were significantly lowered in siRNA (“MORD2”) groups than that of the controls (see also a photomicrograph from a representative mouse in 6H).

The effect of siRNA (“MORD2”) on striatal MOP-r mRNA levels and density is shown in Fig 6. A. Striatal MOP-r mRNA levels in mice infused with siRNA were significantly lower than those of the controls 1 day after infusions (see also a photomicrograph from a representative mouse in 6E). B. Infusions of siRNA into the mouse striatum did not change the MOP-r mRNA levels 7 day after infusions (see also a photomicrograph from a representative mouse in 6F). C. There was not significant difference between the two groups in striatal MOP-r density at day 1 after infusions (see also a photomicrograph from a representative mouse in 6G). D. Striatal MOP-r receptor density levels were significantly lowered in siRNA (“MORD2”) groups than that of the controls (see also a photomicrograph from a representative mouse in 6H).